Beneficial role of curcumin in skin diseases

Advances in Experimental Medicine and Biology

Volumn 595, Issue , 2007, Pages 343-357

  Thangapazham, Rajesh L ^a,b   Sharma, Anuj ^a,b   Maheshwari, Radha K ^a,c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^c Center for Combat Casualty and Life Sustainment Research

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CURCUMIN; CYTOKINE; DOVONEXW; FREE RADICAL; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BOWEN DISEASE; CLINICAL TRIAL; DERMATITIS; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; DRUG WITHDRAWAL; EXTRACELLULAR MATRIX; HUMAN; METABOLIC DISORDER; NONHUMAN; OXIDATIVE STRESS; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RADIATION CARCINOGENESIS; RADIATION INJURY; REVIEW; SCABIES; SCLERODERMA; SKIN ATROPHY; SKIN CANCER; SKIN CARCINOGENESIS; SKIN DISEASE; SKIN INFLAMMATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

CURCUMA LONGA;

EID: 84934438751     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-46401-5_15     Document Type: Review

References (78)

1. A. Maitre, M. Hours, V. Bonneterre, J. Arnaud, M. T. Arslan, P. Carpentier, A. Bergeret, and R. de Gaudemaris, Systemic sclerosis and occupational risk factors: Role of solvents and cleaning products. J Rheumatol 31, 2395 (2004).
2. M. Bovenzi, F. Barbone, F. E. Pisa, A. Betta, L. Romeo, A. Tonello, D. Biasi, and P. Caramaschi, A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 77, 10 (2004).
3. C. T. Derk and S. A. Jimenez, Systemic sclerosis: Current views of its pathogenesis. Autoimmun Rev 2, 181 (2003).
4. S. A.Jimenez, S. Gaidarova, B. Saitta, N. Sandorfi, D. J. Herrich, J. C. Rosenbloom, U. Kucich, W. R. Abrams, and J Rosenbloom, Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts. J Clin Invest 108, 1395 (2001).
5. G. S. Bogatkevich, E. Gustilo, J. C. Oates, C. Feghali-Bostwick, R. A. Harley, R. M. Silver, and A. Ludwicka-Bradley, Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am J Physiol Lung Cell Mol Physiol 288, L190 (2005).
6. E. Tourkina, P. Gooz, J. Pannu, M. Bonner, D. Scholz, S. Hacker, R. M. Silver, M. Trojanowska, and S. Hoffman, Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling, J Biol Chem 280, 13,879 (2005).
7. E. Tourkina, P. Gooz, J. C. Oates, A. Ludwicka-Bradley, R. M. Silver, and S. Hoffman, Curcumin-induced apoptosis in scleroderma lung fibroblasts: Role of protein kinase cepsilon. Am J Respir Cell Mol Biol 31, 28 (2004).
8. M. V. Panchenko, H. W. Farber, and J. H. Korn, Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts. Am J Physiol: Cell Physiol 278, C92 (2000).
9. A. T. Dinkova-Kostova and P. Talalay, Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis 20, 911 (1999).
10. E. Balogun, M. Hoque, P. Gong, E. Killeen, C. J. Green, R. Foresti, J. Alam, and R. Motterlini, Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371, 887 (2003).
11. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima, An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236, 313 (1997).
12. B. Pool-Zobel, S. Veeriah, and F. D. Bohmer, Modulation of xenobiotic metabolising enzymes by anticarcinogens-focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res 591, 74 (2005).
13. D. A. Bloom and A. K. Jaiswal, Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J Biol Chem 278, 44,675 (2003).
14. S. A. Rushworth, R. M. Ogborne, C. A. Charalambos, and M. A. O'Connell, Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. Biochem Biophys Res Commun 341, 1007 (2006).
15. M. Kastelan, L. P. Massari, and I. Brajac, IApoptosis mediated by cytolytic molecules might be responsible for maintenance of psoriatic plaques. Med Hypotheses 21, 21 (2006).
16. A. Pol, M. Bergers, and J. Schalkwijk, Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay. In Vitro Cell Dev Biol Anim 39, 36 (2003).
17. B. Bosman, Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol 7, 324 (1994).
18. J. Miquel, A. Bernd, J. M. Sempere, J. Diaz-Alperi, and A. Ramirez, The curcuma antioxidants: Pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr 34, 37 (2002).
19. C. Hanselmann, C. Mauch, and S. Werner, Haem oxygenase-1: A novel player in cutaneous wound repair and psoriasis? Biochem J 353, 459 (2001).
20. M. Lebwohl, Innovations in the treatment of psoriasis. J Am Acad Dermatol 51, S40 (2004).
21. M. C. Heng, M. K. Song, and M. K. Heng, Elevated phosphorylase kinase activity in psoriatic epidermis: Correlation with increased phosphorylation and psoriatic activity. Br J Dermatol 130, 298 (1994).
22. M. C. Heng, M. K. Song, J. Harker, and M. K. Heng, Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol 143, 937 (2000).
23. H. H. Tonnesen, H. de Vries, J. Karlsen, and G. Beijersbergen van Henegouwen, Studies on curcumin and curcuminoids. IX: Investigation of the photobiological activity of curcumin using bacterial indicator systems. J Pharm Sci 76, 371 (1987).
24. L. Kondapalli, K. Soltani, and M. E. Lacouture, The promise of molecular targeted therapies: Protein kinase inhibitors in the treatment of cutaneous malignancies. J Am Acad Dermatol 53, 291 (2005).
25. C. C. Ramirez, D. G. Federman, and R. S. Kirsner, Skin cancer as an occupational disease: The effect of ultraviolet and other forms of radiation. Int J Dermatol 44, 95 (2005).
26. W. Ding, L. G. Hudson, and K. J. Liu, Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol Cell Biochem 279, 105 (2005).
27. M. A. Azuine and S. V. Bhide, Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer 17, 77 (1992).
28. M. Nagabhushan and S. V. Bhide, Curcumin as an inhibitor of cancer. J Am Coll Nutr 11, 192 (1992).
29. M. T. Huang, Z. Y. Wang, C. A. Georgiadis, J. D. Laskin, and A. H. Conney, Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 13, 2183 (1992).
30. Y. P. Lu, R. L. Chang, M. T. Huang, and A. H. Conney, Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14, 293 (1993).
31. Y. P. Lu, R. L. Chang, Y. R. Lou, M. T. Huang, H. L. Newmark, K. R. Reuhl, and A. H. Conney, Effect of curcumin on 12-O-tetradecanoylphorbol-13- acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. Carcinogenesis 15, 2363 (1994).
32. C. Ishizaki, T. Oguro, T. Yoshida, C. Q. Wen, H. Sueki, and M. Iijima, Enhancing effect of ultraviolet A on ornithine decarboxylase induction and dermatitis evoked by 12-O-tetradecanoylphorbol-13-acetate and its inhibition by curcumin in mouse skin. Dermatology 193, 311(1996).
33. G. T. Bowden, Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat Rev Cancer 4, 23 (2004).
34. A. Grandjean-Laquerriere, S. C. Gangloff, R. Le Naour, C. Trentesaux, W. Hornebeck, and M. Guenounou, Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine 18, 168 (2002).
35. J. W. Cho, K. Park, G. R. Kweon, B. C. Jang, W. K. Baek, M. H. Suh, C. W. Kim, K. S. Lee, and S. I. Suh, Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Exp Mol Med 37, 186 (2005).
36. K. S. Chun, Y. S. Keum, S. S. Han, Y. S. Song, S. H. Kim, and Y. J. Surh, Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 24, 1515 (2003).
37. N. Ahmad, S. K. Katiyar, and H. Mukhtar, Antioxidants in chemoprevention of skin cancer. Curr Probl Dermatol 29, 128 (2001).
38. I. Aukhil, Biology of wound healing. Periodontology 22, 44 (2000).
39. J. Slavin, The role of cytokines in wound healing. J Pathol 178, 5-10 (196).
40. J. Folkman and Y. Shing, Angiogenesis. J Biol Chem 267, 10,931 (1992).
41. J. Folkman and Y. Shing, Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol 313, 355 (1992).
42. G. S. Ashcroft, T. Greenwell-Wild, M. A. Horan, S. M. Wahl, and M. W. Ferguson, Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 55, 1137 (1999).
43. E. Letterer, Morphological manifestations of allergic-hyperergic processes during infectious diseases. Acta Allergol Suppl (Copenh) 3, 79 (1953).
44. J. A. Belperio, M. P. Keane, D. A. Arenberg, C. L. Addison, J. E. Ehlert, M. D. Burdick, and R. M. Strieter, CXC chemokines in angiogenesis. J Leukocyte Biol 68, 1 (2000).
45. K. M. Nadkarni, Curcuma longa. In: K. M. Nadkarni, ed. Indian Materia Medica, Bombay: Popular Prakashan Publishing, 1976.
46. R. K. Maheshwari, A. K. Singh, J. Gaddipati, and R. C. Srimal, Multiple biological activities of curcumin: A short review. Life Sci 78, 2081 (2006).
47. S. Swarnakar, K. Ganguly, P. Kundu, A. Banerjee, P. Maity, and A. V. Sharma, Curcumin regulates expression and activity of matrix metalloproteinases-9 and -2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem 280, 9409 (2005).
48. D. Gopinath, M. R. Ahmed, K. Gomathi, K. Chitra, P. K. Sehgal, and R. Jayakumar, Dermal wound healing processes with curcumin incorporated collagen films. Biomaterials 25, 1911 (2004).
49. T. T. Phan, P. See, S. T. Lee, and S. Y. Chan, Protective effects of curcumin against oxidative damage on skin cells in vitro: Its implication for wound healing. J Trauma 51, 927 (2001).
50. L. M. Khachigian, V. Lindner, A. J. Williams, and T. Collins, Egr-1-induced endothelial gene expression: A common theme in vascular injury. Science 271, 1427 (1997).
51. U. R. Pendurthi and L. V. Rao, Suppression of transcription factor Egr-1 by curcumin. Thromb Res 97, 179 (2000).
52. G. S. Sidhu, A. K. Singh, D. Thaloor, K. K. Banaudha, G. K. Patnaik, R. C. Srimal, and R. K. Maheshwari, Enhancement of wound healing by curcumin in animals. Wound Repair Regen 6, 167 (1998).
53. W. H.Goodson 3rd. and T. Hunt, Wound healing and the diabetic patient. Surg Gynecol Obstet 149, 600 (1997).
54. M. P. Cohen, V. Y. Wu, and J. A. Cohen, Glycated albumin stimulates fibronectin and collagen IV production by glomerular endothelial cells under normoglycemic conditions. Biochem Biophys Res Commun 239, 91 (1997).
55. J. S. Vande Berg, M. C. Robson, and R. J. Mikhail, Extension of the life span of pressure ulcer fibroblasts with recombinant human interleukin-1 beta. Am J Pathol 146, 1273 (1995).
56. K. Moore, F. Ruge, and K. G. Harding, T lymphocytes and the lack of activated macrophages in wound margin biopsies from chronic leg ulcers. Br J Dermatol 137, 188 (1997).
57. L. Pari and P. Murugan, Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J Basic Clin Physiol Pharmacol 16, 257 (2005).
58. P. Suryanarayana, M. Saraswat, T. Mrudula, T. P. Krishna, K. Krishnaswamy, and G. B. Reddy, Curcumin and turmeric delay streptozotocin- induced diabetic cataract in rats. Invest Ophthalmol Vis Sci 46, 2092 (2005).
59. S. Sharma, S. K. Kulkarni, J. N. Agrewala, and K. Chopra, Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol 536, 256 (2006).
60. T. Osawa and Y. Kato, Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann NY Acad Sci 1043, 440 (2005).
61. G. S. Sidhu, H. Mani, J. P. Gaddipati, A. K. Singh, P. Seth, K. K. Banaudha, G. K. Patnaik, and R. K. Maheshwari, Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen 7, 362 (1999).
62. H. Mani, G. S. Sidhu, R. Kumari, J. P. Gaddipati, P. Seth, and R. K. Maheshwari, Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing. Biofactors 16, 29 (2002).
63. R. E. Shore, Overview of radiation-induced skin cancer in humans. Int J Radiat Biol 57, 809 (1990).
64. Q. Gu, D. Wang, C. Cui, Y. Gao, G. Xia, and X. Cui, Effects of radiation on wound healing. J Environ Pathol Toxicol Oncol 17, 117 (1998).
65. R. Rudolph, J. Vande Berge, J. A. Schneider, J. C. Fisher, and W. L. Poolman, Slowed growth of cultured fibroblasts from human radiation wounds. Plast Reconstr Surg 18, 669 (1998).
66. J. F. Qu, T. M. Cheng, L. S. Xu, C. M. Shi, and X. Z. Ran, Effects of total body irradiation injury on the participation of dermal fibroblasts in tissue repair. Sheng Li Xue Bao 54, 395 (2002).
67. S. Song and T. Cheng, The effect of systemic and local irradiation onwound macrophage and repair promoting action of phenytion sodium. Zhonghma Yi Xue Za Zhi 77, 54 (1997).
68. G. C. Jagetia and G. K. Rajanikant, Curcumin treatment enhances the repair and regeneration of wounds in mice exposed to hemibody gamma-irradiation. Plast Reconstr Surg 115, 515 (2005).
69. G. C. Jagetia and G. K. Rajanikant, Effect of curcumin on radiation-impaired healing of excisional wounds in mice. J Wound Care 13, 107 (2004).
70. G. C. Jagetia and G. K. Rajanikant, Role of curcumin, a naturally occurring phenolic compound of turmeric in accelerating the repair of excisionwound, in mice whole-body exposed to various doses of gamma-radiation. J Surg Res 120, 127 (2004).
71. J. H. Distler, J. R. Kalden, S.Gray, and O. Distler, [Vascular changes in the pathogenesis of systemic sclerosis]. Z Rheumatol 63, 446 (2004).
72. T. T. Leong, U. Fearon, and D. J. Veale, Angiogenesis in psoriasis and psoriatic arthritis: Clues to disease pathogenesis. Curr Rheumatol Rep 7, 325 (2005).
73. J. L. Arbiser, X. C. Li, C. F. Hossain, D. G. Nagle, D. M. Smith, P. Miller, B. Govindarajan, J. DiCarlo, K. R. Landis-Piwowar, and Q. P. Dou, Naturally occurring proteasome inhibitors from mate tea (Ilex paraguayensis) serve as models for topical proteasome inhibitors. J Invest Dermatol 125, 207 (2005).
74. M. H. Oak, J. El Bedoui, and V. B. Schini-Kerth, Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 16, 1 (2005).
75. A. K. Singh, G. S. Sidhu, T. Deepa, and R. K. Maheshwari, Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. Cancer Lett 107, 109 (1996).
76. D. Thaloor, A. K. Singh, G. S. Sidhu, P. V. Prasad, H. K. Kleinman, and R. K. Maheshwari, Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9, 305 (1998).
77. A. L. Cheng, C. H. Hsu, J. K. Lin, M. M. Hsu, Y. F. Ho, T. S. Shen, J. Y. Ko, J. T. Lin, B. R. Lin, W. Ming-Shiang, H. S. Yu, S. H. Jee, G. S. Chen, T. M. Chen, C. A. Chen, M. K. Lai, Y. S. Pu, M. H. Pan, Y. J. Wang, C. C. Tsai, and C. Y. Hsieh, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21, 2895 (2001).
78. V. Charles and S. X. Charles, The use and efficacy of Azadirachta indica ADR ('Neem') and Curcuma longa ('Turmeric') in scabies. A pilot study. Trop Geogr Med 44, 178 (1992).